Targeted therapy in cancer and transgenic animal model

被引:1
作者
Inui, A [1 ]
机构
[1] Keio Univ, Grad Sch Med, Dept Clin Mol Med, Div Diabet Digest & Kidney Dis, Kobe, Hyogo, Japan
关键词
D O I
10.1081/CNV-120023783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:819 / 820
页数:2
相关论文
共 4 条
[1]   ErbB2 is essential in the prevention of dilated cardiomyopathy [J].
Crone, SA ;
Zhao, YY ;
Fan, L ;
Gu, YS ;
Minamisawa, S ;
Liu, Y ;
Peterson, KL ;
Chen, J ;
Kahn, R ;
Condorelli, G ;
Ross, J ;
Chien, KR ;
Lee, KF .
NATURE MEDICINE, 2002, 8 (05) :459-465
[2]   The ErbB receptor family: a therapeutic target for cancer [J].
de Bono, JS ;
Rowinsky, EK .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S19-S26
[3]  
Inui A, 2000, PHARMACOL REV, V52, P35
[4]   Cancer studies explore targeted therapy, researchers seek new prevention strategies [J].
Stephenson, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23) :3063-+